CFIHX
Price
$71.15
Change
-$1.60 (-2.20%)
Updated
Dec 18 closing price
HDCVX
Price
$14.74
Change
-$0.37 (-2.45%)
Updated
Dec 18 closing price
Ad is loading...

CFIHX vs HDCVX

Header iconCFIHX vs HDCVX Comparison
Open Charts CFIHX vs HDCVXBanner chart's image
American Funds Capital Income Bldr F3
Price$71.15
Change-$1.60 (-2.20%)
VolumeN/A
CapitalizationN/A
Janus Henderson Responsible Intl Div C
Price$14.74
Change-$0.37 (-2.45%)
VolumeN/A
CapitalizationN/A
CFIHX vs HDCVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CFIHX vs. HDCVX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFIHX is a Buy and HDCVX is a Hold.

FUNDAMENTALS
Fundamentals
CFIHX has more cash in the bank: 108B vs. HDCVX (172M). CFIHX pays higher dividends than HDCVX: CFIHX (3.59) vs HDCVX (2.20). CFIHX was incepted earlier than HDCVX: CFIHX (8 years) vs HDCVX (12 years). CFIHX is a more actively managed with annual turnover of: 106.00 vs. HDCVX (62.00). HDCVX has a lower initial minimum investment than CFIHX: HDCVX (2500) vs CFIHX (1000000). CFIHX annual gain was more profitable for investors over the last year : 10.75 vs. HDCVX (8.56). HDCVX return over 5 years is better than : 28.91 vs. CFIHX (26.51).
CFIHXHDCVXCFIHX / HDCVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years12 years-
Gain YTD9.8816.370155%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets108B172M62,791%
Annual Yield % from dividends3.592.20163%
Returns for 1 year10.758.56126%
Returns for 3 years11.6114.4480%
Returns for 5 years26.5128.9192%
Returns for 10 yearsN/A55.40-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OMC87.75-1.22
-1.37%
Omnicom Group
WRLD111.64-4.55
-3.92%
World Acceptance Corp
NEOG11.64-0.49
-4.04%
Neogen Corp
TLYS3.23-0.15
-4.44%
Tilly's
BTAI0.36-0.04
-8.95%
BioXcel Therapeutics